MetaCap

Editas Medicine Quarterly Cash Flow Statement

NASDAQ: EDITHealth CareBiotechnology: Biological Products (No Diagnostic Substances)USD

1.64-0.07 (-4.09%)

At close: Nov 20, 4:00 PM ET · Delayed 15 min

Editas Medicine free cash flow

In the quarter ended Sep 30, 2026, Editas Medicine generated -$21.2 million of operating cash flow and spent $0 on capital expenditures. That left free cash flow of -$21.2 million, a free-cash-flow margin of -204.4% of revenue.

Summary generated from market data by MetaCap's automated system. Methodology

Editas Medicine cash flow statement (quarterly)

Editas Medicine quarterly cash flow statement
Quarter (USD)Q3 20262026-09-30Q2 20262026-06-30Q1 20262026-03-31Q4 20252025-12-31Q3 20252025-09-30Q2 20252025-06-30Q1 20252025-03-31Q4 20242024-12-31Q3 20242024-09-30Q2 20242024-06-30Q1 20242024-03-31Q4 20232023-12-31
Net Income-23.39M-18.23M-24.98M-5.62M-25.12M-53.23M-76.09M-45.40M-62.14M-67.61M-61.95M-18.87M
Net Income growth (YoY)————————————
Depreciation & Amortization385.00K416.00K483.00K805.00K721.00K1.83M1.92M1.38M1.60M1.42M1.41M1.47M
Stock-Based Compensation2.57M2.19M2.10M2.13M2.23M2.66M2.98M4.02M4.80M5.01M7.58M5.34M
Change in Working Capital-1.58M-14.29M3.20M-31.32M-11.05M-730.00K13.27M-11.67M951.00K5.72M8.55M-7.24M
Operating Cash Flow-21.19M-29.57M-23.06M-36.39M-30.84M-50.21M-47.80M-50.76M-52.59M-57.06M-49.87M-22.24M
Capital Expenditures0-106.00K-92.00K-60.00K-433.00K0-114.00K-540.00K-2.92M-3.49M-1.87M-1.31M
Investing Cash Flow-66.99M-29.80M64.00K58.00K39.57M42.65M56.39M30.96M83.98M51.95M-4.75M62.84M
Debt Repaid000000-2.87M0000—
Financing Cash Flow-468.00K117.53M017.33M17.17M7.41M-1.44M55.51M0322.00K192.00K514.00K
Net Change in Cash-88.65M58.17M-23.00M-19.00M25.90M-150.00K7.15M35.71M31.39M-4.79M-54.42M41.11M
Free Cash Flow-21.19M-29.67M-23.15M-36.45M-31.28M-50.21M-47.91M-51.30M-55.51M-60.56M-51.74M-23.55M

This table shows 12 quarterly periods of Editas Medicine's cash flow statement, from Q3 2026 back to Q4 2023, across 12 line items including net income, depreciation & amortization, stock-based compensation. Values in USD; B = billions, M = millions. Fiscal periods follow EDIT's reporting calendar. What is a cash flow statement?

More financial data